Search - tctmd.com

Displaying 161 - 180 of 492

Sort: Relevancy | Date

News Daily News

Drugs to Tweak RAAS Response No Help in Acute COVID-19, RCTs Show

Caitlin E. Cox

April 19, 2023

News Daily News

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

L.A. McKeown

April 19, 2023

News Opinion CV Team Dispatch

April 2023 News Roundup

L.A. McKeown

April 01, 2023

News Daily News

Borderline Cost-effectiveness for SGLT2 Inhibitors in HFpEF

Todd Neale

March 15, 2023

News Opinion CV Team Dispatch

March 2023 News Roundup

L.A. McKeown

March 15, 2023

News Conference News ACC 2023

IMPLEMENT-HF: ‘Virtual’ Stewardship May Help Optimize GDMT in HFrEF

L.A. McKeown

March 14, 2023

News Conference News ACC 2023

Viability Testing Fails to Find HF Patients Who’d Benefit From PCI in REVIVED-BCIS2

Michael O'Riordan

March 09, 2023

News Conference News ACC 2023

Multifaceted Approach to COORDINATE Diabetes Care Improves GDMT

Yael L. Maxwell

March 07, 2023

News Daily News

Erectile Dysfunction Drugs Show Cardioprotective Effects in Low-risk Men

Yael L. Maxwell

February 21, 2023

News Daily News

Cardiac Biomarkers May Help Refine HF Risk Stratification, Progression

L.A. McKeown

February 17, 2023

News Opinion CV Team Dispatch

February 2023 News Roundup

L.A. McKeown

February 15, 2023

News Daily News

Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis

L.A. McKeown

February 02, 2023

News Daily News

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

L.A. McKeown

January 24, 2023

News Daily News

HFrEF’s Financial Burden May Get Relief From Inflation Reduction Act

L.A. McKeown

January 13, 2023

News Daily News

Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS

Michael O'Riordan

December 30, 2022

News Opinion CV Team Dispatch

December 2022 News Roundup

L.A. McKeown

December 28, 2022

News Daily News

Effect of Intensive BP-Lowering on Cardiac Biomarkers Varies: SPRINT Analysis

Todd Neale

December 23, 2022

News Daily News

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Michael O'Riordan

December 14, 2022

News Daily News

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Michael O'Riordan

December 14, 2022

News Daily News

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Michael O'Riordan

December 08, 2022

Advertisement

Drugs to Tweak RAAS Response No Help in Acute COVID-19, RCTs Show

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

April 2023 News Roundup

Borderline Cost-effectiveness for SGLT2 Inhibitors in HFpEF

March 2023 News Roundup

IMPLEMENT-HF: ‘Virtual’ Stewardship May Help Optimize GDMT in HFrEF

Viability Testing Fails to Find HF Patients Who’d Benefit From PCI in REVIVED-BCIS2

Multifaceted Approach to COORDINATE Diabetes Care Improves GDMT

Erectile Dysfunction Drugs Show Cardioprotective Effects in Low-risk Men

Cardiac Biomarkers May Help Refine HF Risk Stratification, Progression

February 2023 News Roundup

Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

HFrEF’s Financial Burden May Get Relief From Inflation Reduction Act

Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS

December 2022 News Roundup

Effect of Intensive BP-Lowering on Cardiac Biomarkers Varies: SPRINT Analysis

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content